Sign inJoin waitlistJoin the waitlist

Anusha Chidharla

Physician · University of Kansas Hospital and Medical Center

Credentials: · · · · · · · ·

History

University of Kansas Hospital and Medical Center
2025–Present

Hematology and Medical Oncology
University of Kansas School of Medicine
2021–2024
Internal Medicine
University of Illinois College of Medicine at Peoria
2018–2021
Maharajah Institute of Medical Sciences
2011–2015

Research

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in…
Systematic review or meta-analysis · International Journal of Molecular Sciences · 2023 · First of 8 authors · Corresponding · 61 citations
Kidney disease and COVID-19 disease severity-systematic review and meta-analysis
Systematic review or meta-analysis · Clinical and Experimental Medicine · 2022 · 48 citations
Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
EClinicalMedicine · 2020 · 27 citations

Anup Kasi
6 papers
KA
Kriti Agarwal
4 papers · 4 as a resident
RR
Rizwan Rabbani
4 papers · 4 as a resident
ER
Eliot Rapoport
3 papers · 2 as a resident
Salwa Abdelwahed
3 papers · 3 as a fellow
TK
Thoyaja Koritala
3 papers
Weijing Sun
3 papers
PM
Preeti Malik
2 papers · 2 as a resident
PM
Pritika Manaktala-Kochan
2 papers · 2 as a fellow
SG
Sachin Gupta
2 papers
Sakti Chakrabarti
2 papers
SM
Samragnyi Madala
2 papers · 2 as a fellow

Clinical trials

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2025–2029
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2025–2028
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028